Page last updated: 2024-10-21

alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Respiratory Insufficiency

alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid has been researched along with Respiratory Insufficiency in 1 studies

alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid: An IBOTENIC ACID homolog and glutamate agonist. The compound is the defining agonist for the AMPA subtype of glutamate receptors (RECEPTORS, AMPA). It has been used as a radionuclide imaging agent but is more commonly used as an experimental tool in cell biological studies.

Respiratory Insufficiency: Failure to adequately provide oxygen to cells of the body and to remove excess carbon dioxide from them. (Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Algera, H1
van der Schrier, R1
Cavalla, D1
van Velzen, M1
Roozekrans, M1
McMorn, A1
Snape, M1
Horrigan, JP1
Evans, S1
Kiernan, B1
Sarton, E1
Olofsen, E1
Niesters, M1
Dahan, A1

Trials

1 trial available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Respiratory Insufficiency

ArticleYear
Respiratory Effects of the Atypical Tricyclic Antidepressant Tianeptine in Human Models of Opioid-induced Respiratory Depression.
    Anesthesiology, 2022, 10-01, Volume: 137, Issue:4

    Topics: Alfentanil; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Analgesics, Opioid; Antidepres

2022